Gregory Seltzer, MD
Gastroenterology · Sicklerville, NJNPI 1194901553
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Ardelyx, Inc. accounts for 66.4% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $23,737, more than ten times the $436 reported in 2019. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 453 payments — averaging $67.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$20K
- Medtronic$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$832
- Johnson & Johnson$697
- Takeda Pharmaceuticals U.S.A., Inc.$607
- plus $3K from 26 others
What the payments were for
- Consulting fees$4261%
- Speaking & faculty fees$16,30453%
- Travel & lodging$4,98416%
- Food & beverage$8,85429%
- Education$960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 39 | $20,355 |
| Medtronic | 37 | $3,803 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 90 | $1,139 |
| AbbVie | 58 | $832 |
| Johnson & Johnson | 31 | $697 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $607 |
| QOL Medical, LLC | 22 | $466 |
| Boston Scientific | 5 | $404 |
| Regeneron Healthcare Solutions, Inc. | 12 | $297 |
| Bristol Myers Squibb | 16 | $248 |
| Sanofi | 12 | $247 |
| Pfizer | 12 | $193 |
| Ironwood Pharmaceuticals, Inc | 12 | $176 |
| Ferring Pharmaceuticals Inc. | 11 | $169 |
| Ambu Inc. | 2 | $162 |
| Gilead | 8 | $129 |
| Phathom Pharmaceuticals, Inc. | 8 | $113 |
| Daiichi Sankyo Inc. | 8 | $106 |
| Lilly USA, LLC | 5 | $102 |
| Merck | 6 | $83 |
| Braintree Laboratories, Inc. | 4 | $55 |
| Nestle Healthcare Nutrition Inc. | 3 | $47 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Organon | 2 | $29 |
| Evoke Pharma, Inc. | 2 | $27 |
| Redhill Biopharma Inc. | 2 | $27 |
| Intercept Pharmaceuticals, Inc. | 2 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Celltrion USA Inc. | 1 | $18 |
| GE HealthCare | 1 | $17 |
| Covidien LP | 1 | $16 |
| Shionogi Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBSRELA$20,026
- GI Genius$2,882
- EXALT Model D$239
- Tremfya$135
- Sucraid$125
- DUPIXENT$119
- GENERAL - BILIARY DEVICES$100
How this compares
$30,664 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 18 | $487,510 |
| CreonLipase/Protease/Amylase | 21 | $139,106 |
| LinzessLinaclotide | 155 | $96,374 |
| TrulancePlecanatide | 51 | $42,122 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 64 | $10,920 |
| Mesalamine | 22 | $9,128 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 118 | $7,895 |
| Sucralfate | 38 | $6,269 |
| Lubiprostone | 33 | $4,959 |
| Pantoprazole Sodium | 519 | $4,651 |
| Dexlansoprazole DrDexlansoprazole | 25 | $4,549 |
| Colestipol Hcl | 74 | $3,234 |
| Esomeprazole Magnesium | 61 | $2,627 |
| Mesalamine ErMesalamine | 15 | $2,500 |
| Famotidine | 133 | $1,868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $697 | $487,51018 claims |
| AbbVieCreon, Linzess | $832 | $235,480176 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,139 | $42,12251 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $169 | $10,92064 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Sicklerville
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
- Sanket PatelVoorhees$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.